Anna A. Valsecchi

Turin, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Molecular biomarkers in metastatic clear cell renal cell carcinoma treated with first-line immune combinations: a systematic review of phase III randomized clinical trials by Meet-URO group.

Molecular biomarkers in metastatic clear cell renal cell carcinoma treated with first-line immune combinations: a systematic review of phase III randomized clinical trials by Meet-URO group.

Journal: Cancer metastasis reviews
Published: April 02, 2026

Patient-reported financial toxicity within Italian public healthcare system: A cross-sectional analysis in patients with cancer.

Patient-reported financial toxicity within Italian public healthcare system: A cross-sectional analysis in patients with cancer.

Journal: Tumori
Published: February 25, 2026

Inter-hospital heterogeneity in the authorizations of off-label cancer drugs: A project by Associazione Italiana di Oncologia Medica.

Inter-hospital heterogeneity in the authorizations of off-label cancer drugs: A project by Associazione Italiana di Oncologia Medica.

Journal: Tumori
Published: October 18, 2025

KRAS G12C Inhibition in Solid Tumors: Biological Breakthroughs, Clinical Evidence, and Open Challenges.

KRAS G12C Inhibition in Solid Tumors: Biological Breakthroughs, Clinical Evidence, and Open Challenges.

Journal: Cancers
Published: July 21, 2025

Association Between Health-Related Quality of Life Measures and Survival Endpoints in Oncology Clinical Trials and in Clinical Decision Making: A Narrative Review.

Association Between Health-Related Quality of Life Measures and Survival Endpoints in Oncology Clinical Trials and in Clinical Decision Making: A Narrative Review.

Journal: Pharmaceutical medicine
Published: April 28, 2025

Bone Health and Body Composition as Predictive and Prognostic Markers in Metastatic Castration-resistant Prostate Cancer: A Meet-URO Narrative Review.

Bone Health and Body Composition as Predictive and Prognostic Markers in Metastatic Castration-resistant Prostate Cancer: A Meet-URO Narrative Review.

Journal: Clinical genitourinary cancer
Published: April 05, 2025

Press releases of industry-sponsored clinical trials in oncology: Characteristics, timing and financial impact.

Press releases of industry-sponsored clinical trials in oncology: Characteristics, timing and financial impact.

Journal: Journal of cancer policy
Published: February 06, 2025

Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan.

Delphi consensus on the management of adverse events in patients with metastatic triple-negative breast cancer treated with sacituzumab govitecan.

Journal: The oncologist
Published: December 22, 2024

Integration of translational research in phase III trials: A systematic review of breast cancer studies in a 5-year period.

Integration of translational research in phase III trials: A systematic review of breast cancer studies in a 5-year period.

Journal: Breast (Edinburgh, Scotland)
Published: December 16, 2024

Breast-cancer specific comprehensive archive of Patient-Reported Outcome Measures (PROMs) for clinical research and clinical practice in oncology: Results from the PRO4All project.

Breast-cancer specific comprehensive archive of Patient-Reported Outcome Measures (PROMs) for clinical research and clinical practice in oncology: Results from the PRO4All project.

Journal: Breast (Edinburgh, Scotland)
Published: June 27, 2024

Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies.

Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies.

Journal: ESMO open
Published: March 19, 2024

Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey.

Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey.

Journal: Tumori
Published: March 11, 2024
Showing 1-12 of 21

Last Updated: 09/26/2026